EE9500076A - 1,2-sillaga 1,4-dihüdropüridiinide kasutamine ravimitena - Google Patents

1,2-sillaga 1,4-dihüdropüridiinide kasutamine ravimitena

Info

Publication number: EE9500076A
Authority: EE; Estonia
Prior art keywords: dihydropyridines; medicaments; bridged; ch2ch2ch2; ch2ch
Prior art date: 1994-12-16

Application number

EE9500076A

Other languages

English (en)

Inventor

Urbahns Klaus

Heine Hans-Georg

Junge Bodo

Glaser Thomas

Wittka Reilinde

De Vry Jean-Marie-Viktor

Sommermeyer Henning

Original Assignee

Bayer Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-12-16

Filing date

1995-12-15

Publication date

1996-06-17

1995-12-15 Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft

1996-06-17 Publication of EE9500076A publication Critical patent/EE9500076A/et

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Addiction (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Manufacture Of Tobacco Products (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

EE9500076A 1994-12-16 1995-12-15 1,2-sillaga 1,4-dihüdropüridiinide kasutamine ravimitena EE9500076A (et)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4444860A DE4444860A1 (de)	1994-12-16	1994-12-16	Verwendung von 1,2-überbrückten 1,4-Dihydropyridinen als Arzneimittel

Publications (1)

Publication Number	Publication Date
EE9500076A true EE9500076A (et)	1996-06-17

Family

ID=6535985

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9500076A EE9500076A (et)	1994-12-16	1995-12-15	1,2-sillaga 1,4-dihüdropüridiinide kasutamine ravimitena

Country Status (25)

Country	Link
US (2)	US5990121A (et)
EP (2)	EP0924211A3 (et)
JP (1)	JPH08239384A (et)
KR (1)	KR960022517A (et)
CN (1)	CN1059442C (et)
AT (1)	ATE186536T1 (et)
AU (1)	AU709760B2 (et)
CA (1)	CA2165131A1 (et)
CZ (1)	CZ332895A3 (et)
DE (2)	DE4444860A1 (et)
DK (1)	DK0717043T3 (et)
EE (1)	EE9500076A (et)
ES (1)	ES2139824T3 (et)
FI (1)	FI956016L (et)
GR (1)	GR3032394T3 (et)
HU (1)	HUT74166A (et)
IL (1)	IL116386A (et)
MX (1)	MX9505097A (et)
NO (1)	NO955103L (et)
NZ (1)	NZ280661A (et)
PL (1)	PL180439B1 (et)
RU (1)	RU2155765C2 (et)
SI (1)	SI0717043T1 (et)
SK (1)	SK158095A3 (et)
ZA (1)	ZA9510695B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050075359A1 (en) *	2003-03-14	2005-04-07	Rikako Kono	Large conductance calcium-activated K channel opener
US7394475B2 (en) *	2004-02-13	2008-07-01	Infoprint Solutions Company, Llc	Apparatus, system, and method for image registration
EP1782815B1 (en) *	2004-06-23	2010-09-08	Neurotec Pharma, S.L.	Compound for use in the diagnosis of cns acute damage
EP1782812A1 (en) *	2004-06-23	2007-05-09	Neurotec Pharma, S.L.	Compounds for the treatment of inflammation of the central nervous system
CA2603676A1 (en) *	2005-01-07	2006-07-13	Roskamp Research Llc	Compounds for inhibiting beta-amyloid production and methods of identifying the compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE220633C (et) *
DE2210674C3 (de) *	1972-03-06	1981-09-24	Bayer Ag, 5090 Leverkusen	2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US4053614A (en) *	1972-03-06	1977-10-11	Bayer Aktiengesellschaft	1,2-pentamethylene-1,4-dihydropyridine derivatives
US3935220A (en) *	1972-03-06	1976-01-27	Bayer Aktiengesellschaft	Tetrahydroimidazolo[1,2-a]pyridine derivatives
US3951988A (en) *	1972-03-06	1976-04-20	Bayer Aktiengesellschaft	1,2-Pentamethylene-1,4-dihydropyridine derivatives
DE2210633C2 (de) *	1972-03-06	1983-09-22	Bayer Ag, 5090 Leverkusen	Kondensierte Pyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5225566A (en) *	1992-05-08	1993-07-06	American Home Products Corporation	Indazolanonyl derivative of benzopyran

1994
- 1994-12-16 DE DE4444860A patent/DE4444860A1/de not_active Withdrawn
1995
- 1995-12-04 DK DK95119052T patent/DK0717043T3/da active
- 1995-12-04 AT AT95119052T patent/ATE186536T1/de not_active IP Right Cessation
- 1995-12-04 EP EP99105350A patent/EP0924211A3/de not_active Withdrawn
- 1995-12-04 ES ES95119052T patent/ES2139824T3/es not_active Expired - Lifetime
- 1995-12-04 DE DE59507220T patent/DE59507220D1/de not_active Expired - Fee Related
- 1995-12-04 EP EP95119052A patent/EP0717043B1/de not_active Expired - Lifetime
- 1995-12-04 SI SI9530352T patent/SI0717043T1/xx unknown
- 1995-12-06 MX MX9505097A patent/MX9505097A/es unknown
- 1995-12-07 AU AU40294/95A patent/AU709760B2/en not_active Ceased
- 1995-12-08 US US08/569,534 patent/US5990121A/en not_active Expired - Fee Related
- 1995-12-13 CA CA002165131A patent/CA2165131A1/en not_active Abandoned
- 1995-12-13 JP JP7346244A patent/JPH08239384A/ja active Pending
- 1995-12-13 NZ NZ280661A patent/NZ280661A/en unknown
- 1995-12-14 PL PL95311843A patent/PL180439B1/pl unknown
- 1995-12-14 FI FI956016A patent/FI956016L/fi unknown
- 1995-12-14 IL IL11638695A patent/IL116386A/xx not_active IP Right Cessation
- 1995-12-15 RU RU95121078/04A patent/RU2155765C2/ru active
- 1995-12-15 CZ CZ953328A patent/CZ332895A3/cs unknown
- 1995-12-15 EE EE9500076A patent/EE9500076A/et unknown
- 1995-12-15 NO NO955103A patent/NO955103L/no not_active Application Discontinuation
- 1995-12-15 CN CN95120851A patent/CN1059442C/zh not_active Expired - Fee Related
- 1995-12-15 KR KR1019950050396A patent/KR960022517A/ko not_active Ceased
- 1995-12-15 ZA ZA9510695A patent/ZA9510695B/xx unknown
- 1995-12-15 SK SK1580-95A patent/SK158095A3/sk unknown
- 1995-12-15 HU HU9503597A patent/HUT74166A/hu unknown
1999
- 1999-07-28 US US09/362,409 patent/US6147087A/en not_active Expired - Fee Related
2000
- 2000-01-14 GR GR20000400088T patent/GR3032394T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
US6147087A (en)	2000-11-14
FI956016L (fi)	1996-06-17
SI0717043T1 (en)	2000-02-29
FI956016A0 (fi)	1995-12-14
SK158095A3 (en)	1996-09-04
NO955103D0 (no)	1995-12-15
AU709760B2 (en)	1999-09-09
HUT74166A (en)	1996-11-28
GR3032394T3 (en)	2000-05-31
CN1133841A (zh)	1996-10-23
IL116386A (en)	1999-06-20
DK0717043T3 (da)	2000-05-08
AU4029495A (en)	1996-06-27
CN1059442C (zh)	2000-12-13
ATE186536T1 (de)	1999-11-15
EP0717043A1 (de)	1996-06-19
MX9505097A (es)	1997-01-31
PL180439B1 (pl)	2001-02-28
EP0924211A2 (de)	1999-06-23
RU2155765C2 (ru)	2000-09-10
HU9503597D0 (en)	1996-02-28
DE4444860A1 (de)	1996-06-20
EP0717043B1 (de)	1999-11-10
CZ332895A3 (en)	1997-12-17
NZ280661A (en)	1997-06-24
IL116386A0 (en)	1996-03-31
JPH08239384A (ja)	1996-09-17
ZA9510695B (en)	1996-07-03
PL311843A1 (en)	1996-06-24
US5990121A (en)	1999-11-23
KR960022517A (ko)	1996-07-18
EP0924211A3 (de)	1999-07-07
ES2139824T3 (es)	2000-02-16
DE59507220D1 (de)	1999-12-16
NO955103L (no)	1996-06-17
CA2165131A1 (en)	1996-06-17

Publication	Publication Date	Title
EP0733621A4 (en)	1997-04-02	NEW IMIDAZOLE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
DE69013959D1 (de)	1994-12-15	Aminobenzolsulfonsäurederivate.
DE69010100D1 (de)	1994-07-28	Pyrimidinyl herbizides Mittel.
DK705888D0 (da)	1988-12-19	Pyridazinonderivater
DE69434198D1 (de)	2005-01-27	Verfahren zur senkung des serumcholesterinspiegels mit 2,6-dialkyl-4 silyl-phenol derivaten
EE9500076A (et)	1996-06-17	1,2-sillaga 1,4-dihüdropüridiinide kasutamine ravimitena
DE69621877D1 (de)	2002-07-25	4-Indolylpiperazinyl-Derivate
FI956015A0 (fi)	1995-12-14	5-asyyli-1,4-dihydropyridiinien käyttö
DE69017774D1 (de)	1995-04-20	Benzothiazol-derivate als fungizide.
NO972943D0 (no)	1997-06-23	4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
ATE229513T1 (de)	2002-12-15	Disubstituierte trans-3,4,4a,5,6,10b-hexahydro-2h-napht(1,2-b)- ,4-oxazine, verfahren zu deren herstellung und diese enthaltende pharmazeutigsche zusammensetzungen
NO963374D0 (no)	1996-08-13	Substituerte 4H-pyraner
ATE191458T1 (de)	2000-04-15	Benzol-derivate
ATE97409T1 (de)	1993-12-15	Benzodiazepin-analoge.
DE69837628D1 (de)	2007-05-31	Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
ATE195936T1 (de)	2000-09-15	Bis-imide derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitung
DE59002904D1 (de)	1993-11-04	Cyclopropanthiocarbonsaeureamide.
ATE148462T1 (de)	1997-02-15	Isoxazole derivate als lichtschutzmittel
ES2077697T3 (es)	1995-12-01	Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.